Glucose-Enriched Dialysate and Tolerance to Maintenance Hemodialysis

Abstract

10 patients entered a controlled 4-week study to evaluate the effect of a glucose-enriched dialysate (400 mg/ 100 ml) on hemodialysis tolerance. Headache during and after dialysis and post-dialysis fatigue decreased in a statistically significant manner. The average glycemia was only moderately increased with an adequate insulin response. Blood cholesterol and triglycerides did not vary significantly during this short study period.